SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MEDX ... anybody following?
MEDX 31.58+1.4%Nov 5 12:44 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Icebrg7/3/2007 10:24:27 AM
   of 2240
 
A "trial" like no other.

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Primary Outcome Measures:
* Compassionate use, no primary outcome measure [Time Frame: Compassionate use, no primary outcome measure timeframe]

Secondary Outcome Measures:
* Compassionate use, no secondary outcome measure [Time Frame: Compassionate use, no secondary outcome measure timeframe]

Total Enrollment: 400

Study start: July 2007

URL: clinicaltrials.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext